- Title
- Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial
- Creators - without role
- Axel Le Cesne - Institut Gustave RoussyIsabelle Ray-Coquard - Centre Léon BérardBinh Nguyen Bui - Institut BergoniéAntoine Adenis - Centre Oscar LambretMaria Rios - Centre Alexis VautrinFrançois Bertucci - Institut Paoli-CalmettesFlorence Duffaud - Hôpital de la TimoneChristine Chevreau - Institut Claudius RegaudDidier Cupissol - Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier - IRCMAngela Cioffi - Institut Gustave RoussyJean-François Emile - Service d'anatomie pathologique [CHU Ambroise-Paré]Sylvie Chabaud - Centre Léon BérardDavid Pérol - Centre Léon BérardJean-Yves Blay - Department of Medical Oncology [Lyon]
- Publication Details
- Lancet Oncology, Vol.11(10), pp.942-949
- Identifiers
- 9934588109311
- Academic Unit
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-03623804
Journal article
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial
Lancet Oncology, Vol.11(10), pp.942-949
10/2010
Metrics
1 Record Views